(SNCA) |
| 0 (0%) 01-14 13:29 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.02 |
| Resistance 1: | 1.76 |
| Pivot price: | 1.57 |
| Support 1: | 1.34 |
| Support 2: | 1.11 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.001 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 07 Nov 2025
Parkinson Disease SNCA Risk Variants Are Associated With Higher Asymmetric Putamen Dopaminergic Dysfunction - Neurology® Journals
Tue, 14 Oct 2025
Decreased SNCA expression in whole-blood RNA analysis of Parkinson’s disease adjusting for neutrophils - Nature
Mon, 29 Sep 2025
How gene mutations drive dementia in Parkinson's disease - Medical Xpress
Fri, 26 Sep 2025
How Gene Mutations Drive Dementia in Parkinson’s Disease - Yale School of Medicine
Wed, 03 Sep 2025
Arrowhead and Novartis Strike $2B Deal for Parkinson’s Therapy Breakthrough - geneonline.com
Wed, 03 Sep 2025
Arrowhead and Novartis sign agreement for ARO-SNCA - BioWorld MedTech
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
